{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:54:26Z","timestamp":1793325266481,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T00:00:00Z","timestamp":1374883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2162-3619-2-18","type":"journal-article","created":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T08:14:39Z","timestamp":1374912879000},"source":"Crossref","is-referenced-by-count":52,"title":["Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells"],"prefix":"10.1186","volume":"2","author":[{"given":"Jiarui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Nang Paul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vay Liang","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Recker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Guishan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,27]]},"reference":[{"key":"56_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1042\/bj0230536","volume":"23","author":"HG Crabtree","year":"1929","unstructured":"Crabtree HG: Observations on the carbohydrate metabolism of tumours. Biochem J 1929, 23: 3.","journal-title":"Biochem J"},{"key":"56_CR2","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"OH Warburg","year":"1956","unstructured":"Warburg OH: On the origin of cancer cells. Science 1956, 123: 3191.","journal-title":"Science"},{"key":"56_CR3","first-page":"4","volume":"32","author":"LG Straussand","year":"1991","unstructured":"Straussand LG, Conti PS: The applications of PET in clinical oncology. J Nucl Med 1991, 32: 4.","journal-title":"J Nucl Med"},{"key":"56_CR4","first-page":"2","volume":"231","author":"R Lavayssi\u00e8reemail","year":"2004","unstructured":"Lavayssi\u00e8reemail R, Cab\u00e9e AE, Filmont JE: Clinical applications of PET in oncology. Radiology 2004, 231: 2.","journal-title":"Radiology"},{"key":"56_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00280-003-0724-7","volume":"53","author":"JC Maher","year":"2004","unstructured":"Maher JC, Krishan A, Lampidis TJ: Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol 2004, 53: 2.","journal-title":"Cancer Chemother Pharmacol"},{"key":"56_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0006-2952(98)00054-9","volume":"56","author":"A Floridi","year":"1998","unstructured":"Floridi A, Bruno T, Miccadei S, Fanciulli M, Federico A, Paggi MG: Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant Ehrlich ascites tumor cells through modulation of energy metabolism. Biochem Pharmacol 1998, 56: 7. 10.1016\/S0006-2952(98)00040-9","journal-title":"Biochem Pharmacol"},{"key":"56_CR7","first-page":"4661","volume":"41","author":"A Floridi","year":"1981","unstructured":"Floridi A, Paggi MG, D\u2019Atri S, De Martino C, Marcante ML, Silvestrini B, Caputo A: Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res 1981, 41: 4661.","journal-title":"Cancer Res"},{"key":"56_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1158\/0008-5472.CAN-04-4313","volume":"65","author":"RH Xu","year":"2005","unstructured":"Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P: Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 2005, 65: 2.","journal-title":"Cancer Res"},{"key":"56_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(01)00667-X","volume":"173","author":"YH Ko","year":"2001","unstructured":"Ko YH, Pedersenemai PL, Geschwind JF: Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 2001, 173: 1. 10.1016\/S0304-3835(01)00676-0","journal-title":"Cancer Lett"},{"key":"56_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1586\/14737140.4.3.449","volume":"4","author":"JF Geschwind","year":"2004","unstructured":"Geschwind JF, Georgiades CS, Ko YH, Pedersen P: Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma. Expert Rev Anticancer Ther 2004, 4: 3.","journal-title":"Expert Rev Anticancer Ther"},{"key":"56_CR11","first-page":"41","volume":"276","author":"J Boren","year":"2001","unstructured":"Boren J, Cascante M, Marin S, Com\u0131\u0301n-Anduix B, Centelles JJ, Lim S, Bassilian S, Ahmed S, Lee WNP, Boros LG: Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem 2001, 276: 41.","journal-title":"J Biol Chem"},{"key":"56_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/1078-0432.CCR-04-0039","volume":"10","author":"S Gottschalk","year":"2004","unstructured":"Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ: Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin Cancer Res 2004, 10: 19. 10.1158\/1078-0432.CCR-03-0160","journal-title":"Clin Cancer Res"},{"key":"56_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2165\/00129785-200505050-00002","volume":"5","author":"NJ Serkova","year":"2005","unstructured":"Serkova NJ, Boros LG: Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications. Am J Pharmacogenomics 2005, 5: 5.","journal-title":"Am J Pharmacogenomics"},{"key":"56_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-5793(99)00907-2","volume":"456","author":"B Ra\u0131\u0308s","year":"1999","unstructured":"Ra\u0131\u0308s B, Comin B, Puigjaner J, Brandes JL, Creppy E, Saboureau D, Ennamany R, Lee WNP, Boros LG, Cascanteemal M: Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich\u2019s tumor cells through inhibition of the pentose cycle. FEBS Lett 1999, 456: 1. 10.1016\/S0014-5793(99)00907-2","journal-title":"FEBS Lett"},{"key":"56_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1432-1327.2001.01774.x","volume":"268","author":"B Com\u00edn-Anduix","year":"2001","unstructured":"Com\u00edn-Anduix B, Boren J, Martinez S, Moro C, Centelles JJ, Trebukhina R, Petushok N, Lee WNP, Boros LG, Cascante M: The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem 2001, 268: 15. 10.1046\/j.1432-1327.2001.01774.x","journal-title":"Eur J Biochem"},{"key":"56_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.onc.1209597","volume":"25","author":"H Pelicano","year":"2006","unstructured":"Pelicano H, Martin DS, Malt , Xu R-H, Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25: 34.","journal-title":"Oncogene"},{"key":"56_CR17","first-page":"19","volume":"57","author":"LG Boros","year":"1997","unstructured":"Boros LG, Puigjaner J, Cascante M, Lee WNP, Brandes JL, Bassiian S, Yusuf F, Williams RD, Muscarella P, Melvin WS, Schirmer WJ: Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 1997, 57: 19.","journal-title":"Cancer Res"},{"key":"56_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ijc.22227","volume":"119","author":"A Ramos-Montoya","year":"2006","unstructured":"Ramos-Montoya A, Lee WNP, Bassilian S, Lim S, Trebukhina RV, Kazhyna MV, Ciudad CJ, No\u00e9 V, Centelles JJ, Cascante M: Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer. Int J Cancer 2006, 119: 12.","journal-title":"Int J Cancer"},{"key":"56_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1742-4658.2007.05686.x","volume":"274","author":"R Moreno-S\u00e1nchez","year":"2007","unstructured":"Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S, Mar\u00edn-Hern\u00e1ndez A, Saavedra E: Energy metabolism in tumor cells. FEBS J 2007, 274: 6.","journal-title":"FEBS J"},{"key":"56_CR20","first-page":"2","volume":"215","author":"S Rodr\u00edguez-Enr\u00edquez","year":"2006","unstructured":"Rodr\u00edguez-Enr\u00edquez S, Vital-Gonz\u00e1lez PA, Flores-Rodr\u00edguez FL, Mar\u00edn-Hern\u00e1ndez A, Ruiz-Azuara L, Moreno-S\u00e1nchez R: Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells. Toxicol Appl Pharmacol 2006, 215: 2.","journal-title":"Toxicol Appl Pharmacol"},{"key":"56_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pros.2990120112","volume":"12","author":"JC Romijn","year":"1988","unstructured":"Romijn JC, Verkoelen CF, Schroeder FH: Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. Prostate 1988, 12: 1.","journal-title":"Prostate"},{"key":"56_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 1\u20132. 10.1016\/0022-1759(83)90300-9","journal-title":"J Immunol Methods"},{"key":"56_CR23","first-page":"2","volume":"9","author":"H Zhang","year":"2010","unstructured":"Zhang H, Cao R, Lee WN, Deng C, Zhao Y, Lappe J, Recker R, Yen Y, Wang Q, Tsai M, Go VL, Xiao GG: Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathways. J Proteome Res 2010, 9: 2.","journal-title":"J Proteome Res"},{"key":"56_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/ac802566h","volume":"81","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Lee WN, Lim S, Go VL, Xiao J, Cao R, Zhang H, Recker RR, Xiao GG: Quantitative proteomics: measuring protein synthesis using 15 N amino acid labeling in pancreatic cancer cells. Anal Chem 2009, 81: 2. 10.1021\/ac802566h","journal-title":"Anal Chem"},{"key":"56_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/elps.200406145","volume":"26","author":"GG Xiao","year":"2005","unstructured":"Xiao GG, Nel AE, Loo JA: Nitrotyrosine-modified proteins and oxidative stress induced by diesel exhaust particles. Electrophoresis 2005, 26: 1. 10.1002\/elps.200590000","journal-title":"Electrophoresis"},{"key":"56_CR26","first-page":"50","volume":"278","author":"GG Xiao","year":"2003","unstructured":"Xiao GG, Wang M, Li N, Loo JA, Nel AE: Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem 2003, 278: 50.","journal-title":"J Biol Chem"},{"key":"56_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/elps.200500286","volume":"26","author":"XS Jiang","year":"2005","unstructured":"Jiang XS, Tang LY, Cao XJ, Zhou H, Xia QC, Wu JR, Zeng R: Two-dimensional gel electrophoresis maps of the proteome and phosphoproteome of primitively cultured rat mesangial cells. Electrophoresis 2005, 26: 23.","journal-title":"Electrophoresis"},{"key":"56_CR28","first-page":"2","volume":"5","author":"SJ Callister","year":"2006","unstructured":"Callister SJ, Barry RC, Adkins JN, Johnson ET, Qian WJ, Webb-Robertson BJM, Smith RD, Lipton MS: Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J Proteome Res 2006, 5: 2.","journal-title":"J Proteome Res"},{"key":"56_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/cr.2009.2","volume":"19","author":"D Ma","year":"2009","unstructured":"Ma D, Li S, Wang LS, Dai J, Zhao SL, Zeng R: Temporal and spatial profiling of nuclei-associated proteins upon TNF-alpha\/NF-kappaB signaling. Cell Res 2009, 19: 5. 10.1038\/cr.2009.2","journal-title":"Cell Res"},{"key":"56_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1104\/pp.117.3.723","volume":"117","author":"C Chang","year":"1998","unstructured":"Chang C, Stewart RC: The two-component system. Regulation of diverse signaling pathways in prokaryotes and eukaryotes. Plant Physiol 1998, 117: 3.","journal-title":"Plant Physiol"},{"key":"56_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev.biophys.27.1.133","volume":"27","author":"D Barford","year":"1998","unstructured":"Barford D, Das AK, Egloff MP: The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 1998, 27: 133. 10.1146\/annurev.biophys.27.1.133","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"56_CR32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/MMBR.53.4.450-490.1989","volume":"53","author":"JB Stock","year":"1989","unstructured":"Stock JB, Ninfa AJ, Stock AM: Protein phosphorylation and regulation of adaptive responses in bacteria. Microbiol Rev 1989, 53: 4.","journal-title":"Microbiol Rev"},{"key":"56_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.mi.42.100188.000525","volume":"42","author":"AJ Cozzone","year":"1988","unstructured":"Cozzone AJ: Protein phosphorylation in prokaryotes. Annu Rev Microbiol 1988, 42: 97. 10.1146\/annurev.mi.42.100188.000525","journal-title":"Annu Rev Microbiol"},{"key":"56_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcb.2008.10.003","volume":"19","author":"DK Morrison","year":"2009","unstructured":"Morrison DK: The 14\u20133-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009, 19: 1. 10.1016\/j.tcb.2008.10.004","journal-title":"Trends Cell Biol"},{"key":"56_CR35","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.1126\/science.1152337","volume":"319","author":"Z Yuan","year":"2008","unstructured":"Yuan Z, Becker EB, Merlo P, Yamada T, DiBacco S, Konishi Y, Schaefer EM, Bonni A: Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons. Science 2008, 319: 5870.","journal-title":"Science"},{"key":"56_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2006.03.004","volume":"16","author":"G Tzivion","year":"2006","unstructured":"Tzivion G, Gupta VS, Kaplun L, Balan V: 14\u20133-3 proteins as potential oncogenes. Semin Cancer Biol 2006, 16: 3. 10.1016\/j.semcancer.2005.07.008","journal-title":"Semin Cancer Biol"},{"key":"56_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2006.03.003","volume":"16","author":"GW Porter","year":"2006","unstructured":"Porter GW, Khuri FR, Fu H: Dynamic 14\u20133-3\/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol 2006, 16: 3. 10.1016\/j.semcancer.2005.07.008","journal-title":"Semin Cancer Biol"},{"key":"56_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/jcb.22368","volume":"108","author":"JH Pak","year":"2009","unstructured":"Pak JH, Moon JH, Hwang SJ, Cho SH, Seo SB, Kim TS: Proteomic analysis of differentially expressed proteins in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products. J Cell Biochem 2009, 108: 6.","journal-title":"J Cell Biochem"},{"key":"56_CR39","first-page":"2","volume":"9","author":"S Kang","year":"2010","unstructured":"Kang S, Shim HS, Lee JS, Kim DS, Kim HY, Hong SH, Kim PS, Yoon JH, Cho NH: Molecular proteomics imaging of tumor interfaces by mass spectrometry. J Proteome Res 2010, 9: 2.","journal-title":"J Proteome Res"},{"key":"56_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pros.21292","volume":"71","author":"A Basu","year":"2011","unstructured":"Basu A, Banerjee H, Rojas H, Martine SR, Roy S, Jia Z, Lilly MB, De Le\u00f3n M, Casiano CA: Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate 2011, 71: 7.","journal-title":"Prostate"},{"key":"56_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1158\/0008-5472.CAN-07-1622","volume":"67","author":"M Obeid","year":"2007","unstructured":"Obeid M, Panaretakis T, Tesniere A, Joza N, Tufi R, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G: Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from \u201csilent\u201d to immunogenic. Cancer Res 2007, 67: 17.","journal-title":"Cancer Res"},{"key":"56_CR42","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2900","volume":"9","author":"W Kolch","year":"2010","unstructured":"Kolch W, Pitt A: Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer 2010, 9: 618.","journal-title":"Nat Rev Cancer"},{"key":"56_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2009.11.008","volume":"22","author":"S Etienne-Manneville","year":"2010","unstructured":"Etienne-Manneville S: From signaling pathways to microtubule dynamics: the key players. Curr Opin Cell Biol 2010, 22: 1. 10.1016\/j.ceb.2010.01.003","journal-title":"Curr Opin Cell Biol"},{"key":"56_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1158\/1538-7445.AM10-6","volume":"70","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Huang L, Zhao W, Rigas B: Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 2010, 70: 6. 10.1158\/1538-7445.AM10-6","journal-title":"Cancer Res"},{"key":"56_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1096\/fj.06-7464rev","volume":"21","author":"LHK Lim","year":"2007","unstructured":"Lim LHK, Pervaiz S: Annexin 1: the new face of an old molecule. FASEB J 2007, 21: 4.","journal-title":"FASEB J"},{"key":"56_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/path.2400","volume":"216","author":"S Mussunoor","year":"2008","unstructured":"Mussunoor S, Murray GI: The role of annexins in tumour development and progression. J Pathol 2008, 216: 2.","journal-title":"J Pathol"},{"key":"56_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.bjc.6601929","volume":"91","author":"WN Lee","year":"2004","unstructured":"Lee WN, Guo P, Lim S, Bassilian S, Lee ST, Boren J, Cascante M, Go VL, Boros LG: Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment. Br J Cancer 2004, 91: 12.","journal-title":"Br J Cancer"},{"key":"56_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0b013e3181bc44dd","volume":"39","author":"J Xiao","year":"2010","unstructured":"Xiao J, Lee WN, Zhao Y, Cao R, Go VL, Recker RR, Wang Q, Xiao GG: Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media. Pancreas 2010, 39: 1. 10.1097\/MPA.0b013e3181bd51c8","journal-title":"Pancreas"},{"key":"56_CR49","first-page":"20","volume":"29","author":"F Zhao","year":"2010","unstructured":"Zhao F, Mancuso A, Bui TV, Tong X, Gruber JJ, Swider CR, Sanchez PV, Lum JJ, Sayed N, Melo JV, Perl AE, Carroll M, Tuttle SW, Thompson CB: Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene 2010, 29: 20.","journal-title":"Oncogene"},{"key":"56_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.canlet.2005.03.027","volume":"233","author":"J Chen","year":"2006","unstructured":"Chen J, R\u00f6cken C, Nitsche B, Hosius C, Gschaidmeier H, Kahl S, Malfertheiner P, Ebert MPA: The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression. Cancer Lett 2006, 233: 2.","journal-title":"Cancer Lett"},{"key":"56_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.canlet.2008.01.035","volume":"264","author":"Y Takayama","year":"2008","unstructured":"Takayama Y, Kokuryo T, Yokoyama Y, Nagino M, Nimura Y, Senga T, Hamaguchi M: MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth. Cancer Lett 2008, 264: 2.","journal-title":"Cancer Lett"},{"key":"56_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1517\/14728222.12.11.1389","volume":"12","author":"D Mahalingam","year":"2008","unstructured":"Mahalingam D, Giles F: Challenges in developing targeted therapy for pancreatic adenocarcinoma. Expert Opin Ther Targets 2008, 12: 11.","journal-title":"Expert Opin Ther Targets"},{"key":"56_CR53","first-page":"4","volume":"35","author":"F Riveraemail","year":"2009","unstructured":"Riveraemail F, L\u00f3pez-Tarruella S, Vega-Villegas ME, Salcedo M: Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy. Cancer Treat Rev 2009, 35: 4.","journal-title":"Cancer Treat Rev"},{"key":"56_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cdd.2010.113","volume":"18","author":"H Choi","year":"2011","unstructured":"Choi H, Chang J-W, Jung Y-K: Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase. Cell Death Differ 2011, 18: 3.","journal-title":"Cell Death Differ"},{"key":"56_CR55","first-page":"11","volume":"26","author":"M Wang","year":"2005","unstructured":"Wang M, Xiao GG, Li N, Xie Y, Loo JA, Nel AE: Use of a fluorescent phosphoprotein dye to characterize oxidative stress-induced signaling pathway components in macrophage and epithelial cultures exposed to diesel exhaust particle chemicals. Electrophoresis 2005, 26: 11.","journal-title":"Electrophoresis"},{"key":"56_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10735-007-9117-2","volume":"38","author":"H Zreiqat","year":"2007","unstructured":"Zreiqat H, Howlett CR, Gronthos S, Hume D, Geczy CL: S100A8\/S100A9 and their association with cartilage and bone. J Mol Histol 2007, 38: 5.","journal-title":"J Mol Histol"},{"key":"56_CR57","first-page":"1","volume":"94","author":"G Mendon\u00e7a","year":"2010","unstructured":"Mendon\u00e7a G, Mendon\u00e7a DBS, Arag\u00e3o FJL, Cooper LF: The combination of micron and nanotopography by H(2)SO(4)\/H(2)O(2) treatment and its effects on osteoblast-specific gene expression of hMSCs. J Biomed Mater Res A 2010, 94: 1.","journal-title":"J Biomed Mater Res A"},{"key":"56_CR58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pmic.200700480","volume":"8","author":"FY Deng","year":"2008","unstructured":"Deng FY, Liu YZ, Li LM, Jiang C, Wu S, Chen Y, Jiang H, Yang F, Xiong JX, Xiao P, Xiao SM, Tan LJ, Sun X, Zhu XZ, Liu MY, Lei SF, Chen XD, Xie JY, Xiao GG, Liang SP, Deng HW: Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density. Proteomics 2008, 8: 20.","journal-title":"Proteomics"},{"key":"56_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1074\/mcp.M200046-MCP200","volume":"1","author":"JM Pratt","year":"2002","unstructured":"Pratt JM, Petty J, Riba-Garcia I, Robertson DHL, Gaskell SJ, Oliver SG, Beynon RJ: Dynamics of protein turnover, a missing dimension in proteomics. Mol Cell Proteomics 2002, 1: 8.","journal-title":"Mol Cell Proteomics"},{"key":"56_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1152\/japplphysiol.00976.2007","volume":"104","author":"GG Xiao","year":"2008","unstructured":"Xiao GG, Garg M, Lim S, Wong D, Go VL, Lee WN: Determination of protein synthesis in vivo using labeling from deuterated water and analysis of MALDI-TOF spectrum. J Appl Physiol 2008, 104: 3.","journal-title":"J Appl Physiol"},{"key":"56_CR61","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324: 5930.","journal-title":"Science"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-2-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2162-3619-2-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-2-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T22:19:30Z","timestamp":1596233970000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/2162-3619-2-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,27]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1186\/2162-3619-2-18","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,27]]},"article-number":"18"}}